查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1300097

季節性流感疫苗的全球市場（2023 年版）：按疫苗類型、效價、年齡組、分銷渠道、地區和國家劃分的分析、市場洞察和預測（2019-2029 年）

Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)
出版日期: | 出版商: Azoth Analytics | 英文 280 Pages | 訂單完成後即時交付

價格

全球季節性流感疫苗市場規模預計將從2022年的58億美元增至2029年底的93億美元，2024-2029年復合年增長率為7.61%。天氣條件的變化、呼吸道疾病的迅速流行、意識的提高和零售需求的增加是市場的有利增長因素。

該報告提供了全球季節性流感疫苗市場的研究和分析，提供市場規模和預測、區域和細分市場分析、行業趨勢等。

目錄

第一章 市場背景

  • 產品範圍和產品前景
  • 執行摘要
  • 調查方法

第二章 戰略建議

  • 利用數字技術和跟蹤系統
  • 改善疫苗的分發和獲取

3全球季節性流感疫苗市場：表現與預測（2019-2029）

  • 宏觀經濟因素對季節性流感疫苗市場的影響分析
  • 季節性流感疫苗在全球範圍內通過資格預審
  • 流感疫苗接種率
  • 四價流感疫苗組合物
  • 平均價格分析
  • 全球季節性流感疫苗市場：儀表板
  • 全球季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
  • 全球季節性流感疫苗市場：市場產量和復合年增長率（2019-2029）
  • COVID-19 對流感疫苗市場的影響
  • 按疫苗類型劃分的全球季節性流感疫苗市場細分
  • 全球季節性流感疫苗市場細分：按價
  • 按年齡組劃分的全球季節性流感疫苗市場細分
  • 全球季節性流感疫苗市場細分：按分銷渠道

第四章全球季節性流感疫苗市場，區域分析

  • 研究區域範圍
  • 區域快照

5美洲季節性流感疫苗市場：表現與預測（2019-2029）

  • 美洲季節性流感疫苗市場：概況
  • 美洲季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
  • 美洲季節性流感疫苗市場：關鍵因素
  • 按疫苗類型劃分的美洲季節性流感疫苗市場細分
  • 美洲季節性流感疫苗市場細分：按價
  • 按年齡組劃分的美洲季節性流感疫苗市場細分
  • 美洲季節性流感疫苗市場細分：按分銷渠道
  • 按國家/地區劃分的美洲季節性流感疫苗市場細分
    • 美國季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 加拿大季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 美洲其他地區季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）

6歐洲季節性流感疫苗市場：表現與預測（2019-2029）

  • 歐洲季節性流感疫苗市場細分：快照
  • 歐洲季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
  • 歐洲季節性流感疫苗市場：關鍵因素
  • 按疫苗類型劃分的歐洲季節性流感疫苗市場細分
  • 歐洲季節性流感疫苗市場細分：按價
  • 按年齡組劃分的歐洲季節性流感疫苗市場細分
  • 歐洲季節性流感疫苗市場細分：按分銷渠道
  • 按國家/地區劃分的歐洲季節性流感疫苗市場細分
    • 德國季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 英國季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 法國季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 西班牙季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 其他歐洲季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）

7亞太季節性流感疫苗市場：表現與預測（2019-2029）

  • 亞太季節性流感疫苗市場：概況
  • 亞太季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
  • 亞太季節性流感疫苗市場：關鍵因素
  • 按疫苗類型劃分的亞太季節性流感疫苗市場細分
  • 亞太地區季節性流感疫苗市場細分：按價
  • 按年齡組劃分的亞太季節性流感疫苗市場細分
  • 亞太地區季節性流感疫苗市場細分：按分銷渠道
  • 按國家/地區劃分的亞太地區季節性流感疫苗市場細分
    • 中國季節性流感疫苗市場：市場規模及復合年增長率（2019-2029）
    • 日本季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 澳大利亞季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 韓國季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
    • 亞太地區其他季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）

8中東和非洲季節性流感疫苗市場：表現和預測（2019-2029）

  • 中東和非洲季節性流感疫苗市場：概況
  • 中東和非洲季節性流感疫苗市場：市場規模和復合年增長率（2019-2029）
  • 中東和非洲季節性流感疫苗市場：關鍵因素
  • 中東和非洲季節性流感疫苗市場按疫苗類型細分
  • 中東和非洲季節性流感疫苗市場細分：按價
  • 中東和非洲季節性流感疫苗市場按年齡組細分
  • 中東和非洲季節性流感疫苗市場細分：按分銷渠道

第九章市場動態

  • 評估市場動態對全球季節性流感疫苗市場的影響
  • 促進者
  • 抑製劑
  • 趨勢

第十章行業生態系統分析

  • 宏觀經濟因素評估
  • 波特五力分析

第十一章競爭定位

  • 建議各年齡段的季節性流感疫苗
  • 知名企業市場佔有率
  • 公司簡介
    • CSL Seqirus
    • GlaxoSmithKline
    • Sanofi
    • AstraZeneca PLC
    • Abbott Laboratories
    • Viatris
    • Sinovac Biotech
    • Serum Institute of India
    • Daiichi Sankyo
    • Dalian Aleph Biomedical

Executive Summary

Azoth Analytics has released a research report titled "Global Seasonal Influenza Vaccine Market (2023 Edition)" which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine -IIV, Live Attenuated Influenza Vaccine - LAIV), Valency (Quadrivalent, Trivalent), Age Group (Pediatrics, Adults, Elderly) and By Distribution Channel (Hospitals, Pharmacies, Government Supply) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Spain, China, Japan, Australia, South Korea). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Seasonal Influenza Vaccine Market is expected to generate USD 9.3 Billion by the end of 2029, up from USD 5.8 Billion in 2022. A favourable growth element for the Global Seasonal Influenza Vaccine market is the changing weather conditions, rapid transmissions of respiratory diseases, increasing awareness, and increasing demand for retail. Influenza is a significant global health concern, causing a considerable burden of illness, hospitalizations, and deaths each year. As per WHO, an estimated 1 Million people worldwide are infected by seasonal influenza every year, out of which an estimated 290,000 - 650,000 deaths occur due to flu each year.

During the forecast period, 2024-2029, Global Seasonal Influenza Vaccines expected to expand at a CAGR of 7.61%. The global seasonal influenza vaccine is driven by increasing awareness about flu prevention, rising healthcare expenditure, and growing government initiatives for immunization programs.

Prevention and control of seasonal influenza are primarily achieved through annual vaccination. The flu vaccine is formulated each year to protect against the most prevalent strains of the virus. There are different types of influenza vaccines available in the market. The most common ones include trivalent vaccines (protect against three flu strains) and quadrivalent vaccines (protect against four flu strains). These vaccines may be administered through injection (inactivated vaccine) or nasal spray (live attenuated vaccine).

Retail pharmacies provide easy access to seasonal influenza vaccines for the general population. With numerous pharmacy locations in communities, people can conveniently receive their vaccinations without the need for appointments or visits to healthcare facilities, which may be more time-consuming and less accessible.

Leveraging digital technologies and tracking systems in the seasonal influenza vaccine market offers opportunities to improve vaccine distribution, enhance vaccination campaigns, ensure vaccine safety, and enable data-driven decision-making. By harnessing the power of digital solutions, stakeholders can optimize vaccine delivery, increase vaccine uptake, and ultimately contribute to better influenza prevention and control efforts.

Scope of the Report:

  • The report analyses the Seasonal Influenza Vaccine Market by Value (USD Million).
  • The report presents the analysis of Seasonal Influenza Vaccine Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Seasonal Influenza Vaccine Market by Vaccine Type (Inactivated Influenza Vaccine (IIV), Live Attenuated Influenza Vaccine (LAIV)).
  • The report analyses the Seasonal Influenza Vaccine Market by Valency (Quadrivalent, Trivalent).
  • The report analyses the Seasonal Influenza Vaccine Market by Age Group (Pediatrics, Adults, Elderly).
  • The report analyses the Seasonal Influenza Vaccine Market by Distribution Channel (Hospitals, Pharmacies, Government Supply).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include CSL Seqirus, GlaxoSmithKline, Sanofi, AstraZeneca, Abbott Laboratories, Viatris, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, and Dalian Aleph Biomedical.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Strategic Recommendations

  • 2.1 Leveraging digital technologies and tracking systems
  • 2.2 Improved vaccine distribution and access

3. Global Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

  • 3.1 Impact Analysis of Macro Economic Factors on Seasonal Influenza Vaccine Market
  • 3.2 Prequalified Seasonal Influenza Vaccine Worldwide
  • 3.3 Influenza Vaccination Rates
  • 3.4 Quadrivalent Influenza Vaccine Composition
  • 3.5 Average Price Analysis
  • 3.6 Global Seasonal Influenza Vaccine Market: Dashboard
  • 3.7 Global Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 3.8 Global Seasonal Influenza Vaccine Market: Market Production Volume and CAGR, 2019-2029 (in Billion Doses)
  • 3.9 Degree of Impact of Covid 19 on Influenza Vaccine Market
  • 3.10 Global Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type
    • 3.10.1 Global Seasonal Influenza Vaccine Market, By Vaccine Type Overview
    • 3.10.2 Global Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.3 Global Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
  • 3.11 Global Seasonal Influenza Vaccine Market Segmentation : By Valency
    • 3.11.1 Global Seasonal Influenza Vaccine Market, By Valency Overview
    • 3.11.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.11.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.12 Global Seasonal Influenza Vaccine Market Segmentation : By Age Group
    • 3.12.1 Global Seasonal Influenza Vaccine Market, By Age Group Overview
    • 3.12.2 Global Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.12.3 Global Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.12.4 Global Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.13 Global Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel
    • 3.13.1 Global Seasonal Influenza Vaccine Market, By Distribution Channel Overview
    • 3.13.2 Global Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.13.3 Global Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.13.4 Global Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

4. Global Seasonal Influenza Vaccine Market, Regional Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

  • 5.1 Americas Seasonal Influenza Vaccine Market: Snapshot
  • 5.2 Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 5.3 Americas Seasonal Influenza Vaccine Market: Key Factors
  • 5.4 Americas Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type
    • 5.4.1 Americas Seasonal Influenza Vaccine Market, By Vaccine Type Overview
    • 5.4.2 Americas Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
    • 5.4.3 Americas Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
  • 5.5 Americas Seasonal Influenza Vaccine Market Segmentation : By Valency
    • 5.5.1 Americas Seasonal Influenza Vaccine Market, By Valency Overview
    • 5.5.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.6 Americas Seasonal Influenza Vaccine Market Segmentation : By Age Group
    • 5.6.1 Americas Seasonal Influenza Vaccine Market, By Age Group Overview
    • 5.6.2 Americas Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.6.3 Americas Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.6.4 Americas Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.7 Americas Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel
    • 5.7.1 Americas Seasonal Influenza Vaccine Market, By Distribution Channel Overview
    • 5.7.2 Americas Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.3 Americas Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.4 Americas Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.8 Americas Seasonal Influenza Vaccine Market Segmentation : By Country
    • 5.8.1 United States Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.1.1 United States Seasonal Influenza Vaccine Market, By Vaccine Type
      • 5.8.1.2 United States Seasonal Influenza Vaccine Market, By Valency
      • 5.8.1.3 United States Seasonal Influenza Vaccine Market, By Age Group
      • 5.8.1.4 United States Seasonal Influenza Vaccine Market, By Distribution Channel
    • 5.8.2 Canada Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.2.1 Canada Seasonal Influenza Vaccine Market, By Vaccine Type
      • 5.8.2.2 Canada Seasonal Influenza Vaccine Market, By Valency
      • 5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Age Group
      • 5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Distribution Channel
    • 5.8.3 Rest of Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.3.1 Rest of Americas Seasonal Influenza Vaccine Market, By Vaccine Type
      • 5.8.3.2 Rest of Americas Seasonal Influenza Vaccine Market, By Valency
      • 5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Age Group
      • 5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Distribution Channel

6. Europe Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

  • 6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot
  • 6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 6.3 Europe Seasonal Influenza Vaccine Market: Key Factors
  • 6.4 Europe Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type
    • 6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Vaccine Overview
    • 6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)
    • 6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
  • 6.5 Europe Seasonal Influenza Vaccine Market Segmentation : By Valency
    • 6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Valency Overview
    • 6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.6 Europe Seasonal Influenza Vaccine Market Segmentation : By Age Group
    • 6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview
    • 6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.7 Europe Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel
  • 6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot
  • 6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 6.3 Europe Seasonal Influenza Vaccine Market: Key Factors
  • 6.4 Europe Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type
    • 6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Vaccine Overview
    • 6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)
    • 6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
  • 6.5 Europe Seasonal Influenza Vaccine Market Segmentation : By Valency
    • 6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Valency Overview
    • 6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.6 Europe Seasonal Influenza Vaccine Market Segmentation : By Age Group
    • 6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview
    • 6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.7 Europe Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel
    • 6.7.1 Europe Seasonal Influenza Vaccine Market, By Distribution Channel Overview
    • 6.7.2 Europe Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.7.3 Europe Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.7.4 Europe Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.8 Europe Seasonal Influenza Vaccine Market Segmentation : By Country
    • 6.8.1 Germany Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.1.1 Germany Seasonal Influenza Vaccine Market, By Vaccine Type
      • 6.8.1.2 Germany Seasonal Influenza Vaccine Market, By Valency
      • 6.8.1.3 Germany Seasonal Influenza Vaccine Market, By Age Group
      • 6.8.1.4 Germany Seasonal Influenza Vaccine Market, By Distribution Channel
    • 6.8.2 United Kingdom Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.2.1 United Kingdom Seasonal Influenza Vaccine Market, By Vaccine Type
      • 6.8.2.2 United Kingdom Seasonal Influenza Vaccine Market, By Valency
      • 6.8.2.3 United Kingdom Seasonal Influenza Vaccine Market, By Age Group
      • 6.8.2.4 United Kingdom Seasonal Influenza Vaccine Market, By Distribution Channel
    • 6.9.3 France Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.9.3.1 France Seasonal Influenza Vaccine Market, By Vaccine Type
      • 6.9.3.2 France Seasonal Influenza Vaccine Market, By Valency
      • 6.9.3.3 France Seasonal Influenza Vaccine Market, By Age Group
      • 6.9.3.4 France Seasonal Influenza Vaccine Market, By Distribution Channel
    • 6.9.4 Spain Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.9.4.1 Spain Seasonal Influenza Vaccine Market, By Vaccine Type
      • 6.9.4.2 Spain Seasonal Influenza Vaccine Market, By Valency
      • 6.9.4.3 Spain Seasonal Influenza Vaccine Market, By Age Group
      • 6.9.4.4 Spain Seasonal Influenza Vaccine Market, By Distribution Channel
    • 6.9.5 Rest of Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.9.5.1 Rest of Europe Seasonal Influenza Vaccine Market, By Vaccine Type
      • 6.9.5.2 Rest of Europe Seasonal Influenza Vaccine Market, By Valency
      • 6.9.5.3 Rest of Europe Seasonal Influenza Vaccine Market, By Age Group
      • 6.9.5.4 Rest of Europe Seasonal Influenza Vaccine Market, By Distribution Channel

7. Asia Pacific Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

  • 7.1 Asia Pacific Seasonal Influenza Vaccine Market: Snapshot
  • 7.2 Asia Pacific Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 7.3 Asia Pacific Seasonal Influenza Vaccine Market: Key Factors
  • 7.4 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type
    • 7.4.1 Asia Pacific Seasonal Influenza Vaccine Market, By Vaccine Type Overview
    • 7.4.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
    • 7.4.3 Asia Pacific Seasonal Influenza Vaccine Market Size, Live Attenuated Influenza Vaccine (LIIV) Museum, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.5 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Valency
    • 7.5.1 Asia Pacific Seasonal Influenza Vaccine Market, By Valency Overview
    • 7.5.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.6 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Age Group
    • 7.6.1 Asia Pacific Seasonal Influenza Vaccine Market, By Age Group Overview
    • 7.6.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.6.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.6.4 Asia Pacific Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.7 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel
    • 7.7.1 Asia Pacific Seasonal Influenza Vaccine Market, By Distribution Channel Overview
    • 7.7.2 Asia Pacific Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.3 Asia Pacific Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.4 Asia Pacific Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.8 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Country
    • 7.8.1 China Seasonal Influenza Vaccine Market Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.1.1 China Seasonal Influenza Vaccine Market, By Vaccine Type
      • 7.8.1.2 China Seasonal Influenza Vaccine Market, By Valency
      • 7.8.1.3 China Seasonal Influenza Vaccine Market, By Age Group
      • 7.8.1.4 China Seasonal Influenza Vaccine Market, By Distribution Channel
    • 7.8.2 Japan Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.2.1 Japan Seasonal Influenza Vaccine Market, By Vaccine Type
      • 7.8.2.2 Japan Seasonal Influenza Vaccine Market, By Valency
      • 7.8.2.3 Japan Seasonal Influenza Vaccine Market, By Age Group
      • 7.8.1.4 Japan Seasonal Influenza Vaccine Market, By Distribution Channel
    • 7.8.3 Australia Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.3.1 Australia Seasonal Influenza Vaccine Market, By Vaccine Type
      • 7.8.3.2 Australia Seasonal Influenza Vaccine Market, By Valency
      • 7.8.3.3 Australia Seasonal Influenza Vaccine Market, By Age Group
      • 7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel
    • 7.8.4 South Korea Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.3.1 South Korea Seasonal Influenza Vaccine Market, By Vaccine Type
      • 7.8.3.2 South Korea Seasonal Influenza Vaccine Market, By Valency
      • 7.8.3.3 South Korea Seasonal Influenza Vaccine Market, By Age Group
      • 7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel
    • 7.8.5 Rest of APAC Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.5.1 Rest of APAC Seasonal Influenza Vaccine Market, By Vaccine Type
      • 7.8.5.2 Rest of APAC Seasonal Influenza Vaccine Market, By Valency
      • 7.8.5.3 Rest of APAC Seasonal Influenza Vaccine Market, By Age Group
      • 7.8.5.4 Rest of APAC Seasonal Influenza Vaccine Market, By Distribution Channel

8. Middle East & Africa Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

  • 8.1 Middle East & Africa Seasonal Influenza Vaccine Market: Snapshot
  • 8.2 Middle East & Africa Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 8.3 Middle East & Africa Seasonal Influenza Vaccine Market: Key Factors
  • 8.4 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type
    • 8.4.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Vaccine Type Overview
    • 8.4.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
    • 8.4.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)
  • 8.5 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Valency
    • 8.5.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Valency Overview
    • 8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.6 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Age Group
    • 8.6.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Age Group Overview
    • 8.6.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.7 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel
    • 8.7.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Distribution Channel Overview
    • 8.7.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.4 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

9. Market Dynamics

  • 9.1 Impact assessment of Market Dynamics on Global Seasonal Influenza Vaccine Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Macro-Economic Factor Assessment
  • 10.2 Porter Analysis

11. Competitive Positioning

  • 11.1 Recommended Seasonal Influenza Vaccines for Different Age Groups
  • 11.2 Market Share of Prominent Companies
  • 11.3 Company Profiling
    • 11.3.1 CSL Seqirus
    • 11.3.2 GlaxoSmithKline
    • 11.3.3 Sanofi
    • 11.3.4 AstraZeneca PLC
    • 11.3.5 Abbott Laboratories
    • 11.3.6 Viatris
    • 11.3.7 Sinovac Biotech
    • 11.3.8 Serum Institute of India
    • 11.3.9 Daiichi Sankyo
    • 11.3.10 Dalian Aleph Biomedical

List of Figures

List of Figures

  • Figure 1: Influenza Vaccination Rates, Total % of population aged 65 and Above
  • Figure 2: Global Seasonal Influenza Vaccine Market Size, By Value, 2019-2022 (USD Million)
  • Figure 3: Global Seasonal Influenza Vaccine Market Size, By Value, 2023-2029 (USD Million)
  • Figure 4: Global Seasonal Influenza Vaccine Market Share, By Valency Type, 2022 (%)
  • Figure 5: Global Seasonal Influenza Vaccine Market Size, By Volume, 2019-2022 (Billion Doses)
  • Figure 6: Global Seasonal Influenza Vaccine Market Size, By Volume, 2023-2029 (Billion Doses)
  • Figure 7: Global Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 8: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Inactivated Influenza Vaccine (IIV), 2019H-2029F (USD Million)
  • Figure 9: Global Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 10: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Live Attenuated Influenza Vaccine (LAIV), 2019H-2029F (USD Million)
  • Figure 11: Global Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 12: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Quadrivalent, 2019H-2029F (USD Million)
  • Figure 13: Global Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 14: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Trivalent, 2019H-2029F (USD Million)
  • Figure 15: Global Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 16: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Pediatrics, 2019H-2029F (USD Million)
  • Figure 17: Global Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 18: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Adults, 2019H-2029F (USD Million)
  • Figure 19: Global Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 20: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Elderly, 2019H-2029F (USD Million)
  • Figure 21: Global Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 22: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Hospitals, 2019H-2029F (USD Million)
  • Figure 23: Global Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 24: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Pharmacies, 2019H-2029F (USD Million)
  • Figure 25: Global Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 26: Global Seasonal Influenza Vaccine Market Absolute Opportunity, By Government Supply, 2019H-2029F (USD Million)
  • Figure 27: Americas Seasonal Influenza Vaccine Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 28: Americas Seasonal Influenza Vaccine Market Share, By Vaccine Type, 2022 (%)
  • Figure 29: Americas Seasonal Influenza Vaccine Market , By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 30: Americas Seasonal Influenza Vaccine Market , By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 31: Americas Seasonal Influenza Vaccine Market , By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 32: Americas Seasonal Influenza Vaccine Market , By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 33: Americas Seasonal Influenza Vaccine Market , By Pediatrics Age Group, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 34: Americas Seasonal Influenza Vaccine Market , By Adults Age Group, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 35: Americas Seasonal Influenza Vaccine Market , By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 36: Americas Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 37: Americas Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 38: Americas Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 39: United States Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 40: United States Seasonal Influenza Vaccine Market Value, By Valency, 2022 (USD Million)
  • Figure 41: United States Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 42: United States Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 43: United States Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 44: United States Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 45: Canada Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 46: Canada Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 47: Canada Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 48: Canada Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 49: Canada Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 50: Canada Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 51: Rest of Americas Seasonal Influenza Vaccine Market , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 52: Rest of Americas Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 53: Rest of Americas Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 54: Rest of Americas Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 55: Rest of Americas Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 56: Rest of Americas Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 57: Europe Seasonal Influenza Vaccine Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 58: Europe Seasonal Influenza Vaccine Market Share, By Valency Type, 2022 (%)
  • Figure 59: Europe Seasonal Influenza Vaccine Market, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 60: Europe Seasonal Influenza Vaccine Market, By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 61: Europe Seasonal Influenza Vaccine Market, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 62: Europe Seasonal Influenza Vaccine Market, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 63: Europe Seasonal Influenza Vaccine Market, By Pediatrics Age Group, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 64: Europe Seasonal Influenza Vaccine Market, By Adults Age Group, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 65: Europe Seasonal Influenza Vaccine Market, By Elderly Age Group, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 66: Europe Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 67: Europe Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 68: Europe Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 69: Germany Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 70: Germany Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 71: Germany Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 72: Germany Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 73: Germany Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 74: Germany Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 75: United Kingdom Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 76: United Kingdom Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 77: United Kingdom Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 78: United Kingdom Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 79: United Kingdom Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 80: United Kingdom Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 81: France Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 82: France Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 83: France Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 84: France Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 85: France Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 86: France Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 87: Spain Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 88: Spain Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 89: Spain Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 90: Spain Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 91: Spain Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 92: Spain Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 93: Rest of Europe Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 94: Rest of Europe Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 95: Rest of Europe Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 96: Rest of Europe Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 97: Rest of Europe Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 98: Rest of Europe Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 99: Asia Pacific Seasonal Influenza Vaccine Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 100: Asia Pacific Seasonal Influenza Vaccine Market Share, By Valency Type, 2022 (%)
  • Figure 101: Asia Pacific Seasonal Influenza Vaccine Market, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 102: Asia Pacific Seasonal Influenza Vaccine Market, By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 103: Asia Pacific Seasonal Influenza Vaccine Market, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 104: Asia Pacific Seasonal Influenza Vaccine Market, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 105: Asia Pacific Seasonal Influenza Vaccine Market, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 106: Asia Pacific Seasonal Influenza Vaccine Market, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 107: Asia Pacific Seasonal Influenza Vaccine Market, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 108: Americas Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 109: Americas Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 110: Asia Pacific Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 111: China Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 112: China Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 113: China Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 114: China Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 115: China Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 116: China Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 117: Japan Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 118: Japan Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 119: Japan Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 120: Japan Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 121: Japan Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 122: Japan Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 123: Australia Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 124: Australia Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 125: Australia Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 126: Australia Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 127: Australia Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 128: Australia Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 129: South Korea Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 130: South Korea Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 131: South Korea Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 132: South Korea Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 133: South Korea Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 134: South Korea Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 135: Rest of Asia Pacific Seasonal Influenza Vaccine Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 136: Rest of Asia Pacific Seasonal Influenza Vaccine Market Value, By Vaccine Type, 2022 (USD Million)
  • Figure 137: Rest of Asia Pacific Seasonal Influenza Vaccine Market Share, By Vaccine Type, By Value, 2022 (%)
  • Figure 138: Rest of Asia Pacific Seasonal Influenza Vaccine Market Share, By Valency, By Value, 2022 (%)
  • Figure 139: Rest of Asia Pacific Seasonal Influenza Vaccine Market Share, By Age Group, By Value, 2022 (%)
  • Figure 140: Rest of Asia Seasonal Influenza Vaccine Market Share, By Distribution Channel, By Value, 2022 (%)
  • Figure 141: Middle East & Africa Seasonal Influenza Vaccine Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 142: Middle East & Africa Seasonal Influenza Vaccine Market Share, By Valency Type, 2022 (%)
  • Figure 143: Middle East & Africa Seasonal Influenza Vaccine Market, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 144: Middle East & Africa Seasonal Influenza Vaccine Market, By Live Attenuated Influenza Vaccine (LAIV), By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 145: Middle East & Africa Seasonal Influenza Vaccine Market, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 146: Middle East & Africa Seasonal Influenza Vaccine Market, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 147: Middle East & Africa Seasonal Influenza Vaccine Market, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 148: Middle East & Africa Seasonal Influenza Vaccine Market, By Adults, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 149: Middle East & Africa Seasonal Influenza Vaccine Market, By Elderly Age Group, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 150: Middle East & Africa Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 151: Middle East & Africa Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 152: Middle East & Africa Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 153: Global Impact of Drivers and Restraints
  • Figure 154: Market Share of Prominent Companies in Seasonal Influenza Vaccine Electronics, 2022 (%)
  • Figure 155: CSL Revenue, 2020-2022 (USD Million)
  • Figure 156: CSL Revenue , By Business Segments, 2022 (%)
  • Figure 157: CSL Revenue, By Geographical Segment, 2022 (%)
  • Figure 158: GSK Revenue, 2020-2022 (USD Million)
  • Figure 159: GSK Revenue , By Business Segments, 2022 (%)
  • Figure 160: GSK Revenue, By Geographical Segment, 2022 (%)
  • Figure 161: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 162: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 163: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 164: AstraZeneca PLC Revenues, 2020-2022 (USD Million)
  • Figure 165: AstraZeneca PLC Revenues, By Geographic Segments, 2022 (%)
  • Figure 166: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 167: Abbott Laboratories Revenues, 2020-2022 (USD Million)
  • Figure 168: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
  • Figure 169: Abbott Laboratories Revenue , By Business Segments, 2022 (%)
  • Figure 170: Viatris Revenue, 2020-2022 (USD Million)
  • Figure 171: Viatris Revenue , By Product Segments, 2022 (%)
  • Figure 172: Viatris Revenue, By Geographical Segment, 2022 (%)

List of Tables:

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: WHO Prequalified Seasonal Influenza Vaccine Suppliers, Products, and Descriptions, 2020

Table A3: Quadrivalent Influenza Vaccine Composition, 20222023

Table A4: Average Price Analysis, Influenza Vaccine Per Dose*, By Type

Table A5: United States Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A6: United States Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A7: United States Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A8: United States Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A9: United States Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A10: United States Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A11: United States Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A12: United States Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A13: Canada Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A14: Canada Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A15: Canada Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A16: Canada Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A17: Canada Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A18: Canada Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A19: Canada Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A20: Canada Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A21: Rest of Americas Seasonal Influenza Vaccine Market , By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A22: Rest of Americas Seasonal Influenza Vaccine Market , By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A23: Rest of Americas Seasonal Influenza Vaccine Market , By Valency, By Value, 2019-2022 (USD Million)

Table A24: Rest of Americas Seasonal Influenza Vaccine Market , By Valency, By Value, 2023-2029 (USD Million)

Table A25: Rest of Americas Seasonal Influenza Vaccine Market , By Age Group, By Value, 2019-2022 (USD Million)

Table A26: Rest of Americas Seasonal Influenza Vaccine Market , By Age Group, By Value, 2023-2029 (USD Million)

Table A27: Rest of Americas Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A28: Rest of Americas Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A29: Germany Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A30: Germany Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A31: Germany Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A32: Germany Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A33: Germany Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A34: Germany Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A35: Germany Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A36: Germany Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A37: United Kingdom Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A38: United Kingdom Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A39: United Kingdom Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A40: United Kingdom Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A41: United Kingdom Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A42: United Kingdom Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A43: United Kingdom Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A44: United Kingdom Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A45: France Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A46: France Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A47: France Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A48: France Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A49: France Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A50: France Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A51: France Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A52: France Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A53: Spain Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A54: Spain Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A55: Spain Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A56: Spain Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A57: Spain Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A58: Spain Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A59: Spain Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A60: Spain Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A61: Rest of Europe Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A62: Rest of Europe Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A63: Rest of Europe Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A64: Rest of Europe Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A65: Rest of Europe Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A66: Rest of Europe Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A67: Rest of Europe Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A68: Rest of Europe Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A69: China Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A70: China Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A71: China Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A72: China Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A73: China Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A74: China Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A75: China Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A76: China Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A77: Japan Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A78: Japan Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A79: Japan Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A80: Japan Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A81: Japan Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A82: Japan Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A83: Japan Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A84: Japan Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A85: Australia Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A86: Australia Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A87: Australia Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A88: Australia Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A89: Australia Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A90: Australia Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A91: Australia Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A92: Australia Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A93: South Korea Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A94: South Korea Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A95: South Korea Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A96: South Korea Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A97: South Korea Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A98: South Korea Seasonal Influenza Vaccine Market, By Age Group, By Value, 2023-2029 (USD Million)

Table A99: South Korea Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A100: South Korea Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A101: Rest of Asia Pacific Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2019-2022 (USD Million)

Table A102: Rest of Asia Pacific Seasonal Influenza Vaccine Market, By Vaccine Type, By Value, 2023-2029 (USD Million)

Table A103: Rest of Asia Pacific Seasonal Influenza Vaccine Market, By Valency, By Value, 2019-2022 (USD Million)

Table A104: Rest of Asia Pacific Seasonal Influenza Vaccine Market, By Valency, By Value, 2023-2029 (USD Million)

Table A105: Rest of Asia Pacific Seasonal Influenza Vaccine Market, By Age Group, By Value, 2019-2022 (USD Million)

Table A106: Rest of Asia Pacific Seasonal Influenza Vaccine Market, BY Age Group, By Value, 2023-2029 (USD Million)

Table A107: Rest of Asia Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A108: Rest of Asia Seasonal Influenza Vaccine Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A109: Recommended Seasonal Influenza Vaccines for Different Age Groups: 20222023 Influenza Season

Table A110: Recommended Seasonal Influenza Vaccines for Different Age Groups: 20222023 Influenza Season

Table A111: Recommended Seasonal Influenza Vaccines for Different Age Groups: 20222023 Influenza Season

Table A112: CSL Key Company Financials, 2020-2022

Table A113: GSK Key Company Financials, 2020-2022

Table A114: Sanofi Key Financials, 2020-2022

Table A115: AstraZeneca PLC Key Financials, 2020-2022

Table A117: Abbott Laboratories Key Financials, 2020-2022

Table A118: Viatris Key Company Financials, 2020-2022